Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
-
1501
Morphing mesh.
Published 2025“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”
-
1502
Bending moment in the pressure zone.
Published 2025“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”
-
1503
Axial forces in the tension zone.
Published 2025“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”
-
1504
VPF and VIPF.
Published 2025“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”
-
1505
-
1506
-
1507
-
1508
-
1509
-
1510
-
1511
-
1512
-
1513
Baseline characteristics of the study sample<sup>β</sup>μ.
Published 2024“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
-
1514
The flow diagram of the study (CONSORT, 2010).
Published 2024“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
-
1515
-
1516
-
1517
-
1518
-
1519
-
1520